KR20230172710A - Health functional food composition for improving menopausal men's health containing Perilla frutescens var. acuta Kudo extract - Google Patents

Health functional food composition for improving menopausal men's health containing Perilla frutescens var. acuta Kudo extract Download PDF

Info

Publication number
KR20230172710A
KR20230172710A KR1020220073206A KR20220073206A KR20230172710A KR 20230172710 A KR20230172710 A KR 20230172710A KR 1020220073206 A KR1020220073206 A KR 1020220073206A KR 20220073206 A KR20220073206 A KR 20220073206A KR 20230172710 A KR20230172710 A KR 20230172710A
Authority
KR
South Korea
Prior art keywords
health
functional food
extract
chazugi
health functional
Prior art date
Application number
KR1020220073206A
Other languages
Korean (ko)
Inventor
박현준
박민정
정현묵
구연경
박연희
Original Assignee
코스맥스바이오 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코스맥스바이오 주식회사 filed Critical 코스맥스바이오 주식회사
Priority to KR1020220073206A priority Critical patent/KR20230172710A/en
Publication of KR20230172710A publication Critical patent/KR20230172710A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/20Agglomerating; Granulating; Tabletting
    • A23P10/28Tabletting; Making food bars by compression of a dry powdered mixture
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/40Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/302Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명의 차즈기 열수 추출물을 유효성분으로 포함하는 갱년기 남성건강 개선용 건강기능식품 조성물을 제공하고 이를 이용한 실험을 실시한 결과, 정자의 수 및 운동성 개선, 테스토스테론 수치 개선, 항산화능 증가, 고환 장애 개선이 확인되는 효과가 있었다.As a result of providing a health functional food composition for improving menopausal men's health containing the chazugi thermal water extract of the present invention as an active ingredient and conducting experiments using the same, the results showed that the number and motility of sperm were improved, testosterone levels were improved, antioxidant capacity was increased, and testicular disorders were improved. This had a confirmed effect.

Description

차즈기 추출물을 포함하는 갱년기 남성건강 개선용 건강기능식품 조성물 및 이를 이용한 건강기능식품{Health functional food composition for improving menopausal men's health containing Perilla frutescens var. acuta Kudo extract}Health functional food composition for improving menopausal men's health containing chazugi extract and health functional food using the same {Health functional food composition for improving menopausal men's health containing Perilla frutescens var. acuta Kudo extract}

본 발명은 갱년기 남성건강을 개선할 수 있는 건강기능식품 조성물에 관한 것으로, 고환 기능 개선을 통한 차즈기 추출물의 갱년기 남성건강 증진이 가능한 차즈기 추출물을 포함하는 갱년기 남성건강 개선용 건강기능식품 조성물 및 이를 이용한 건강기능식품에 관한 것이다.The present invention relates to a health functional food composition that can improve menopausal men's health, and a health functional food composition for improving menopausal men's health containing a Chazugi extract capable of improving menopausal men's health through improving testicular function, and This is about health functional foods using this.

남성 갱년기는 연령에 따른 테스토스테론 결핍에 의해 나타나는 현상이다. 여성과는 다르게 모든 남성에게 나타나는 증상은 아니며 개인차가 큰 질병이다. 최근 진행된 한 연구결과에 따르면 40대가 되면서 혈중 테스토스테론 농도는 매년 1.6%가 감소되며 70대에는 30대의 50%, 880대에는 30% 수준으로 감소하게 된다. Male menopause is a phenomenon caused by age-related testosterone deficiency. Unlike women, this symptom does not appear in all men and is a disease that varies greatly from person to person. According to the results of a recent study, as you enter your 40s, your blood testosterone concentration decreases by 1.6% every year, in your 70s it decreases to 50% of that in your 30s, and in your 880s it decreases to 30%.

대표적인 증상으로는 성욕감소, 발기부전, 무기력함, 집중력 감소, 불면증, 근육량 감소, 우울감 등이 있으며 매년 증상을 호소하며 병원을 찾는 환자들이 증가하는 추세이다. Representative symptoms include decreased libido, erectile dysfunction, lethargy, decreased concentration, insomnia, decreased muscle mass, and depression, and the number of patients visiting hospitals complaining of symptoms is increasing every year.

아시아·태평양 5개국(한국, 호주, 홍콩, 대만, 태국) 45세 이상 남성 1,000명을 대상으로 실시한 '남성갱년기에 대한 인식 및 태도조사' 결과에 따르면, 45세 이상 남성 2명중 1명(약 53%)이 남성갱년기증후군 관련 증상을 경험하고, 이 중 한국 남성 76%가 남성갱년기 증상을 경험한 것으로 나타나 5개국 중가장 높은 수치를 보인다. According to the results of the 'Perception and Attitude Survey on Male Menopause' conducted on 1,000 men aged 45 or older in five Asia-Pacific countries (Korea, Australia, Hong Kong, Taiwan, and Thailand), one in two men aged 45 or older (approx. 53%) experience symptoms related to andropause syndrome, and among these, 76% of Korean men experience andropause symptoms, the highest figure among the five countries.

국내 생식노화에 따른 남성 생식능력 감소 증상은 꾸준히 증가하고 있는 추세이지만 뚜렷한 치료 방법이 부재하다. 널리 사용되는 경구약물, 호르몬 치료제 등은 성기능 회복, 골다공증이나 골밀도의 개선, 근력 회복 및 지력 호전을 목표로 하고 있다. 그러나, 대부분 장기복용하면서 투약해야 하며 크고 작은 부작용이 동반되어 증상개선에 도움을 주는 자연유래 기능성식품의 개발이 요구된다.In Korea, symptoms of decreased male fertility due to reproductive aging are steadily increasing, but there is no clear treatment method. Widely used oral medications and hormonal treatments aim to restore sexual function, improve osteoporosis or bone density, restore muscle strength, and improve intellectual power. However, most of them must be administered for a long period of time and are accompanied by large and small side effects, so the development of natural functional foods that help improve symptoms is required.

남성갱년기의 직접적인 원인은 고환에서 분비되는 테스토스테론 수치 감소이다. 테스토스테론은 2차 성징시 생식기 발달과 성욕 발달 외에도 정자 생성 유도, 정자 활성, 단백질 합성 및 뼈 성장 촉진,생식 기관 기능 유지 등 다양한 기능을 하는 호르몬이다. The direct cause of male menopause is a decrease in testosterone levels secreted by the testes. Testosterone is a hormone that has a variety of functions, including the development of genital organs and sexual desire during secondary sexual characteristics, as well as inducing sperm production, sperm activity, promoting protein synthesis and bone growth, and maintaining reproductive organ function.

한편, 차즈기(蘇葉; Perilla frutescens (L.) Britton var. acuta (Thunb.) Kudo)는 생물학적 분류로 피자식물문, 쌍떡잎식물강, 꿀풀과에 속하는 1년초 약용식물로서 우리나라와 중국에 분포한다. 줄기는 곧추서고 네모지며 전주(全株)에 자색을 띠고 향기가 있고, 잎은 대생하고 넓은 난형으로 끝은 뾰족하고 밑은 둥글거나 다소 쐐기 모양이며 가장자리에 톱니가 있으며, 양면에 털이 있으며 특히 맥 위에 긴 털이 있고 엽병이 길다. Meanwhile, Perilla frutescens (L.) Britton var. acuta (Thunb.) Kudo) is an annual medicinal plant belonging to the angiosperm phylum, dicotyledon class, and Lamiaceae in biological classification and is distributed in Korea and China. do. The stem is erect and square, the entire stem is purple and fragrant, and the leaves are opposite, broadly ovate, pointed at the end, round or somewhat wedge-shaped at the base, serrated at the edges, hairy on both sides, especially with veins. It has long hairs on top and long petioles.

꽃은 8~9월에 연한 자색으로 피고 줄기와 가지 끝, 위쪽의 잎짬에 총상화서로 달린다. 꽃받침은 2개로 갈라지고 위쪽 것은 다시 3열, 아래쪽 것은 2열하며 통부의 내외에 털이 있다. 화관은 짧은 통상 순형이고 하순이 상순보다 약간 길며 수술은 2강 웅예이고 과실은 분과로 둥글며 꽃받침 안에 들어 있다. Flowers bloom in light purple from August to September and grow in racemes at the ends of stems and branches, and on the upper leaves. The calyx is split into two, the upper one has three rows, the lower one has two rows, and there are hairs on the inside and outside of the tube. The corolla is usually short and labial, the lower lip is slightly longer than the upper lip, the stamens are two-strong, and the fruit is round and contained within the calyx.

본종은 전체에 자색을 띠며 분과는 원형이고 그물무늬가 있다. 잎과 줄기는 약용으로 쓰이고 어린잎과 종자는 식용한다. 어린 잎은 들깨잎과 구분이 어려울 정도로 비슷하며, 차즈기에 들어 있는 페릴알데히드로 만든 설탕은 정상 설탕보다 2,000배 정도 강한 감미료이므로 담배·장·치약 등에 사용한다. 잎이 자줏빛이 아니고 녹색인 것을 청소엽(for. viridis)이라고 한다. 청소엽은 꽃이 흰색이고 향기가 차즈기보다 강하며 약재로 많이 사용한다.The main species is purple overall, and the divisions are circular and have a net pattern. The leaves and stems are used for medicinal purposes, and the young leaves and seeds are edible. The young leaves are so similar to perilla leaves that it is difficult to distinguish them, and the sugar made from peryl aldehyde contained in chazugi is a sweetener that is about 2,000 times stronger than normal sugar, so it is used in cigarettes, intestines, toothpaste, etc. Leaves that are green rather than purple are called viridis. The leaves have white flowers, have a stronger scent than chazugi, and are often used as medicine.

본 발명은 기존의 갱년기 남성건강 개선용 건강기능식품에서 발생하는 부작용을 줄일 수 있도록 자연유래의 원료인 차조기 추출물을 포함하는 건강기능식품 조성물을 제공하고자 한다.The present invention seeks to provide a health functional food composition containing perilla extract, a natural raw material, to reduce side effects occurring in existing health functional foods for improving menopausal health.

국내 공개특허번호 제10-2020-0072148호에는 복합 한약 소재를 이용한 남성갱년기 개선용 조성물 이를 이용한 건강식품에 관한 것으로, 남성갱년기의 개별증상에만 작용하지 않고 여러 증상에 복합적으로 작용하는 한약 소재를 통해 우울증, 생식기능, 성기능, 골다공증, 근위축을 개선하고 궁극적으로 남성갱년기를 개선할 수 있는 복합 한약 소재를 이용한 남성개년기 개선용 조성물 및 이를 이용한 건강식품에 관하여 개시하고 있다.Domestic Patent Publication No. 10-2020-0072148 relates to a composition for improving male menopause using complex herbal medicine materials and a health food using the same. It uses herbal medicine ingredients that act not only on individual symptoms of andropause but also on various symptoms. A composition for improving male genitalia using complex herbal medicine materials that can improve depression, reproductive function, sexual function, osteoporosis, muscular atrophy, and ultimately improve male menopause, and a health food using the same are disclosed. 국내 등록특허번호 제10-1870940호에는 야관문과 홍삼을 건강식품의 재료로 활용함으로써 남성호르몬인 테스토스테론의 분비가 증강되어 남성 갱년기 증후군을 개선시켜 건강에 유용한 건강식품조성물에 관하여 개시하고 있다.Domestic registered patent number 10-1870940 discloses a health food composition useful for health by improving male menopausal syndrome by enhancing the secretion of testosterone, a male hormone, by using night gate and red ginseng as ingredients for health food. 국내 공개특허번호 제10-2018-0000136호에는 TM3 세포의 사멸을 억제하는 효과가 있는 오신채를 유효성분으로 함유하는 남성 갱년기 개선용 건강기능식품 및 남성 갱년기 예방 또는 치료용 약학 조성물에 관하여 개시하고 있다.Domestic Patent Publication No. 10-2018-0000136 discloses a health functional food for improving male menopause and a pharmaceutical composition for preventing or treating male menopause containing Shinchae, which has the effect of inhibiting the death of TM3 cells, as an active ingredient. . 국내 공개특허번호 제10-2015-0038906호에는 홍삼, 산약, 구기자, 산수유, 울금과 같은 생약의 추출물을 포함하며, 남성 갱년기 증후군의 여러 증상의 예방 또는 치료에 효과가 있는 생약 추출물을 포함하는 후기 발현 남성 성선기능저하증 내지 남성 갱년기 증후군 예방 또는 치료용 조성물 및 건강 기능성 식품에 관하여 개시하고 있다.Domestic Patent Publication No. 10-2015-0038906 includes extracts of herbal medicines such as red ginseng, wild herb, goji berry, cornelian cherry, and turmeric, and contains extracts of herbal medicines that are effective in preventing or treating various symptoms of male menopausal syndrome. Disclosed is a composition for preventing or treating male hypogonadism or male menopausal syndrome and a health functional food.

본 발명은 기존의 남성 갱년기 개선용 건강식품에서 발생하는 부작용의 문제를 해결하기 위하여 자연 유래의 동아시아에서 약용식물로 사용되던 차즈기(자소엽)의 남성건강 증진효과를 확인하고 이를 이용한 추출물을 포함하는 건강기능식품 조성물 및 이의 건강기능식품을 제공하고자 한다. In order to solve the problem of side effects occurring in existing health foods for improving male menopause, the present invention confirmed the male health improvement effect of chazugi (perilla leaf), which is of natural origin and used as a medicinal plant in East Asia, and included extracts using it. The aim is to provide health functional food compositions and health functional foods thereof.

본 발명은 차즈기 열수 추출물을 유효성분으로 포함하는 갱년기 남성건강 개선용 건강기능식품 조성물을 제공한다. 상기 차즈기 열수 추출물을 유효성분으로 포함하는 갱년기 남성건강 개선용 건강기능식품 조성물은, 약제학적으로 허용 가능한 담체 부형제 또는 이들의 혼합물을 더 포함하고, 상기 조성물의 제형이 정제, 캡슐제, 연질캡슐제, 환제, 과립제 및 드링크제를 포함하는 군에서 선택된 어느 하나인 것일 수 있다.The present invention provides a health functional food composition for improving menopausal health containing Chazugi thermal water extract as an active ingredient. The health functional food composition for improving menopausal men's health containing the Chazugi thermal water extract as an active ingredient further includes a pharmaceutically acceptable carrier excipient or a mixture thereof, and the formulation of the composition is tablet, capsule, or soft capsule. It may be any one selected from the group including tablets, pills, granules, and drinks.

또한 본 발명의 다른 일실시예는 바람직하게는 상기 방법으로 제조되는 갱년기 남성건강 개선용 건강 기능식품을 제공하는 것일 수 있다.In addition, another embodiment of the present invention may be to provide a health functional food for improving menopausal health, preferably manufactured by the above method.

본 발명에서는 부설판에 의한 고환장애가 유도되어 남성갱년기 증상이 나타는 동물모델을 사용하였다. 갱년기 증상을 나타내는 동물모델에 다양한 농도 (100, 200mg/kg)의 차즈기추출물 투여한 결과 정자의 수 및 운동성 개선, 테스토스테론 수치 개선, 항산화능 증가, 고환 장애 개선 등 증상이 개선됨을 확인하였다.In the present invention, an animal model in which testicular dysfunction was induced by busulfan and andropause symptoms appeared was used. As a result of administering various concentrations (100, 200 mg/kg) of Chazugi extract to animal models showing menopausal symptoms, it was confirmed that symptoms were improved, including improvement in sperm count and motility, improvement in testosterone levels, increase in antioxidant capacity, and improvement in testicular disorders.

도 1은 실험예 2에 따라 체중, 고환, 상대적 고환 무게 측정결과를 나타낸다.
도 2는 실험예 3에 따른 고환 조직학적 분석 결과를 나타낸다.
도 3은 실험예 4에 따른 정자수 및 운동성 측정결과를 나타낸다.
도 4는 실험예 5에 따른 혈중 테스토스테론 및 FSH 수칙 측정 결과를 나타낸다.
도 5는 실험예 6,7에 따른 항산화효소 활성과 효소를 암호화하는 유전자 발현량 결과를 나타낸다.
Figure 1 shows the results of measuring body weight, testes, and relative testicular weight according to Experimental Example 2.
Figure 2 shows the results of testicular histological analysis according to Experimental Example 3.
Figure 3 shows the results of measuring sperm count and motility according to Experimental Example 4.
Figure 4 shows the results of measuring blood testosterone and FSH standards according to Experimental Example 5.
Figure 5 shows the results of antioxidant enzyme activity and gene expression levels encoding the enzyme according to Experimental Examples 6 and 7.

이하, 본 발명의 차즈기 추출물을 포함하는 갱년기 남성건강 개선용 건강기능식품 조성물 및 이를 이용한 건강기능식품의 실험예를 들어 상세히 설명하면 다음과 같다. Hereinafter, the health functional food composition for improving menopausal men's health containing the Chazugi extract of the present invention and the health functional food using the same will be described in detail with an experimental example as follows.

<차즈기 열수추출물의 제조><Manufacture of Chazugi hot water extract>

건조된 차즈기 잎 100g을 증류수로 수세한 다음 증류수로 500ml 을 가하여, 환류 추출기 100℃에서 3시간 동안 가열, 추출하였다. 여과지를 이용하여 여과한 후, 여액을 감압 농축하였다. 100 g of dried chazugi leaves were washed with distilled water, then 500 ml of distilled water was added, and extracted by heating in a reflux extractor at 100°C for 3 hours. After filtration using filter paper, the filtrate was concentrated under reduced pressure.

여과 후 남은 잔사에 다시 동량의 증류수를 사용하여 동일 과정으로 2번 더 추출, 여과 및 감압 농축하였다. 농축된 열수 추출물을 동결건조기를 이용 하여 48시간 동결 건조시켰다. 이상의 방법으로 상기 열수 추출물은 추출 용매에 따라 차즈기 잎 열수 추출물을 수득하여 하기 실험예의 시료로 사용하였다.The residue remaining after filtration was extracted twice more using the same amount of distilled water, filtered, and concentrated under reduced pressure. The concentrated hot water extract was freeze-dried for 48 hours using a freeze dryer. By the above method, the hot water extract of Chazugi leaf was obtained according to the extraction solvent and used as a sample in the following experimental example.

본 발명의 실험예에 따르면 차즈기 추출물의 남성갱년기 개선효과를 확인하기 위해 실험동물에게 차즈기 추출물을 투여하고 이를 통해 증상개선 여부와 정도를 분석하였고, 고환장애를 유도한 동물모델을 이용하여 대표적인 남성갱년기 원인인 테스토스테론 수치와 정지의 수와 움직임, 고환의 조직학적 분석, 항산화능을 평가하였다.According to an experimental example of the present invention, in order to confirm the effect of Chazugi extract on improving andropause, Chazugi extract was administered to experimental animals and the presence and extent of symptom improvement were analyzed, and a representative testicular disorder-induced animal model was used. Testosterone levels, the causes of andropause, number and movement of pauses, histological analysis of testes, and antioxidant capacity were evaluated.

<실험예 1> 동물모델 및 갱년기증상 유도<Experimental Example 1> Animal model and induction of menopausal symptoms

본 발명의 실험예 1에 따라 사용된 동물모델은 C57B6/L mice를 사용하였으며 1주간의 적응기간 후 10마리씩 네 그룹으로 분류되었다. Group1 은 대조군; 어떤 물질도 처리 하지 않은 군이고 Group2는 갱년기 유도군이고, Group3은 갱년기 유도 + 차즈기 추출물 100mg/kg 섭취군이며 Group4는 갱년기 유도 + 차즈기 추출물 200mg/kg 섭취군을 나타낸다.The animal model used according to Experimental Example 1 of the present invention was C57B6/L mice, and after a one-week adaptation period, they were divided into four groups of 10 mice each. Group1 is the control group; Group 2 is the group that was not treated with any substances, Group 2 is the menopause induction group, Group 3 is the menopause induction + 100mg/kg intake of chazugi extract, and Group 4 is the menopause induction + 200mg/kg intake of chazugi extract.

갱년기 증상은 부설판 (Busulfan, 1,4-butanediol dimethanesulfonate) 투여에 의해 유도되었으며 40mg/kg의 부설판을 3주 간격으로 2회 투여하였다. 증상이 유도된 동물모델에 각 농도별 차즈기 추출물을 35일간 경구투여한 후 증상 변화를 살펴보았다.Menopausal symptoms were induced by administration of Busulfan (1,4-butanediol dimethanesulfonate), and 40 mg/kg of Busulfan was administered twice at 3-week intervals. Changes in symptoms were examined after oral administration of Chazugi extract at each concentration for 35 days to an animal model in which symptoms were induced.

<실험예 2> 체중 및 고환무게 측정<Experimental Example 2> Measurement of body weight and testicular weight

상기 실험예 1의 종료 후 실험동물의 체중을 측정하고 고환을 적출하여 무게를 측정하였다. 도 1은 실험예 2에 따라 체중, 고환, 상대적 고환 무게 측정결과를 나타낸다. After completion of Experimental Example 1, the weight of the experimental animals was measured, the testes were removed, and the weight was measured. Figure 1 shows the results of measuring body weight, testes, and relative testicular weight according to Experimental Example 2.

대조군에 비해 남성갱년기 유도 모델에서 체중과 고환의 무게, 체중대비 고환의 무게 모두 감소하였다 (p<0.05). 그러나 차즈기추출물 투여군에서 감소된 수치가 회복하는 경향을 보였으며 절대적, 상대적 고환무게는 저농도, 고농도 투여군 모두 유의하게 (p<0.05) 회복되었다.Compared to the control group, body weight, testicular weight, and testicular weight relative to body weight were all decreased in the andropause induced model ( p <0.05). However, in the chazugi extract administration group, the decreased values tended to recover, and absolute and relative testicular weight recovered significantly ( p <0.05) in both the low and high concentration administration groups.

<실험예 3> 고환의 조직학적 분석<Experimental Example 3> Histological analysis of testes

실험예 2에 따라 적출된 고환 내 정자가 생성되는 세정관 (seminiferous tubules)과 이를 구성하는 세정관 생식상피 (germinal epithelium)의 상태확인을 위해 조직학적 분석을 진행하였다.Histological analysis was performed to confirm the condition of the seminiferous tubules where sperm are produced in the testes extracted according to Experimental Example 2 and the germinal epithelium that constitutes them.

적출한 고환을 고정시킨 후 통상적인 조직 제작과정에 따라 파라핀 블록을 만든 후 5um 두께의 절편을 얻은 다음 hematoxylin과 eosin (H&E) 염색을 실시하였다. 절편 내 원형 또는 원형에 가까운 20개의 관을 무작위로 선택하여 세정관과 세정관 생식상피 직경을 측정하였다.After fixing the extracted testis, a paraffin block was made according to the usual tissue preparation process, and then a 5-μm-thick section was obtained and hematoxylin and eosin (H&E) staining was performed. Twenty round or near-circular tubes within the section were randomly selected and the diameters of the seminiferous ducts and seminiferous genital epithelium were measured.

도 2는 실험예 3에 따른 고환 조직학적 분석 결과를 나타낸다. 대조군의 세정관 현미경 사진은 세정관의 정자발생 활성이 정상적으로 보이지만 갱년기 유도 그룹에서는 생식 상피 부형성을 가진 세정관 위축이 나타났다. Figure 2 shows the results of testicular histological analysis according to Experimental Example 3. Micrographs of the seminiferous tubules in the control group showed normal spermatogenic activity in the seminiferous tubules, but the menopausal induction group showed seminiferous tubule atrophy with reproductive epithelial dysplasia.

도 2에 도시된 정자(화살표), 세포 생식 상피(검은 막대), 세르톨리 세포(asterisks)의 직경이 관찰(A) 가능하며 세정관 총 직경(TD) 및 생식 세포 직경(CD)의 단면 값을 그래프로 표현하였다(B). 차즈기 추출물 투여에 의해 부설판으로 유도된 조직학적 변화는 상당히 개선되었으며 100, 200mg/kg의 추출물 투여 시, 세정관과 세정과 생식상피의 직경은 갱년기 유도군에 비해 유의하게(p<0.05) 증가하였다. (*p < 0.001 vs control, #p < 0.001 vs 갱년기 유도군, PFA : 차즈기추출물, P. frutescens var. acuta).The diameters of spermatozoa (arrows), cellular germ epithelium (black bars), and Sertoli cells (asterisks) shown in Figure 2 can be observed (A) and the cross-sectional values of seminiferous tubule total diameter (TD) and germ cell diameter (CD). is expressed graphically (B). The histological changes induced by Busulfan were significantly improved by administration of Chazugi extract, and when administering 100 and 200 mg/kg of extract, the diameters of the seminiferous ducts and the genital epithelium were significantly ( p <0.05) compared to the menopausal induction group. increased. (* p < 0.001 vs control, # p < 0.001 vs menopausal induction group, PFA: Chazugi extract, P. frutescens var . acuta).

<실험예 4> 정자 수 및 운동성 측정<Experimental Example 4> Measurement of sperm count and motility

가위로 절개한 실험동물의 부고환을 phosphate-buffered saline에 넣어준 다음 10분간 incubation하여 정자를 채취하였다. 채취된 정자는 현미경 관찰을 통해 정자의 수를 측정하였고 정자의 수 대비 운동성을 갖는 정자의 비율을 계산하였다.The epididymis of an experimental animal cut with scissors was placed in phosphate-buffered saline and incubated for 10 minutes to collect sperm. The number of sperm collected was measured through microscopic observation, and the ratio of motile sperm to the number of sperm was calculated.

도 3은 실험예 4에 따른 정자수 및 운동성 측정결과를 나타낸다. 정자의 수와 운동성은 부설판에 의한 갱년기 유도 모델에서 현저하게 감소하였으며 차즈기 추출물 투여 시, 두 농도 모두 정자의 수가 유의미하게 증가하였다. 그러나 정자의 운동성은 고동도의 차즈기 추출물 투여군에서만 유의미한 증가를 관찰하였다.Figure 3 shows the results of measuring sperm count and motility according to Experimental Example 4. The number and motility of sperm were significantly reduced in the menopausal induction model by busulfan, and when administered with Chazugi extract, the number of sperm was significantly increased at both concentrations. However, a significant increase in sperm motility was observed only in the group administered high-dose chazugi extract.

<실험예 5> 혈중 테스토스테론 및 FSH (난포자극호르몬) 수치 측정<Experimental Example 5> Measurement of blood testosterone and FSH (follicle stimulating hormone) levels

테스토스테론은 2차 성징유도와 세정관에 작용하여 정자를 만들고 성욕을 유발하는 중요한 호르몬이며 FSH는 성선(Gonad gland)을 자극하는 호르몬으로 정자의 분화와 성숙을 유도하며 성호르몬 분비를 촉진하는 역할을 한다. 두 호르몬 수치 확인을 위해 동물모델의 심장에서 blood sample을 확보하였으며 원심분리를 통해 혈청을 분리하여 enzyme-linked immunosorbent assay kits를 활용하여 호르몬 수치를 확인하였다.Testosterone is an important hormone that induces secondary sexual characteristics and acts on the seminiferous duct to produce sperm and induce sexual desire. FSH is a hormone that stimulates the gonad gland, inducing sperm differentiation and maturation and promoting sex hormone secretion. do. To check the levels of the two hormones, a blood sample was obtained from the heart of the animal model, the serum was separated by centrifugation, and the hormone levels were confirmed using enzyme-linked immunosorbent assay kits.

도 4는 실험예 5에 따른 혈중 테스토스테론 및 FSH 수칙 측정 결과를 나타낸다. 혈청 테스토스테론 및 FSH 수치는 대조군에 비해 갱년기 유도 그룹에서 유의하게 감소하였다 (p < 0.001). 그러나 차즈기추출물 투여시 부설판 유도 이상 혈청 테스토스테론 호르몬 수치를 유의미하게(p< 0.01) 개선시킨 반면, 혈청 FSH 수치에는 유의미한 영향을 미치지 않았다.Figure 4 shows the results of measuring blood testosterone and FSH standards according to Experimental Example 5. Serum testosterone and FSH levels were significantly decreased in the menopausal induction group compared to the control group ( p < 0.001). However, while administration of Chazugi extract significantly ( p < 0.01) improved busulfan-induced abnormal serum testosterone hormone levels, it had no significant effect on serum FSH levels.

<실험예 6> 항산화능 테스트<Experimental Example 6> Antioxidant activity test

항산화능 테스트를 위해 동결건조된 고환조직을 균질화하여 실험을 진행하였다. malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx) 활성 측정키트를 사용하였다.To test antioxidant capacity, experiments were conducted by homogenizing freeze-dried testicular tissue. Malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPx) activity measurement kits were used.

도 5는 실험예 6에 따른 항산화능 테스트 결과를 나타낸다. 고환조직의 SOD 및 GPx 효소 활성은 부설판 유도 갱년기 모델에서 대조군 대비 유의하게 감소하였으나 차즈기 추출물투여는 감소된 활성을 유의하게 개선시켰다. 대조적으로 지질과산화의 결과물인 MDA 수치는 갱년기 유도 모델이서 유의하게 증가하였으며 차즈기 추출물 투여 후 유의하게 개선되었다 (도 5 A, B, C). Figure 5 shows the results of the antioxidant capacity test according to Experimental Example 6. SOD and GPx enzyme activities in testicular tissue were significantly decreased compared to the control group in the busulfan-induced menopausal model, but administration of Chazugi extract significantly improved the decreased activity. In contrast, MDA levels, which are a result of lipid peroxidation, significantly increased in the menopausal induction model and were significantly improved after administration of Chazugi extract (Figure 5 A, B, C).

<실험예 7> Real-time qPCR을 통한 mRNA 비교 분석<Experimental Example 7> Comparative analysis of mRNA through real-time qPCR

동결건조된 고환조직에 TRIzol시약을 넣어 total RNA를 추출한 후 cDNA로 전환하여 qPCR 분석을 진행하였다. 활성이 확인된 유전자는 Sod1, Gpx1이며 internal control로 베타액틴을 사용하여 상대적 발현량을 표시하였다.TRIzol reagent was added to the freeze-dried testicular tissue to extract total RNA, which was then converted to cDNA and subjected to qPCR analysis. Genes confirmed to be active were Sod1 and Gpx1, and beta-actin was used as an internal control to display relative expression levels.

도 5는 실험예 7에 따른 항상화 효소를 암호화하는 유전자 발현량 결과를 나타낸다. 유전자 발현량 역시 앞선 결과와 마찬가지로 갱년기 유도 모델에서 SOD와 GPx를 암호화하는 유전자 Sod1, Gpx1의 발현량이 대조군 대비 유의하게 감소하였으며 차즈기추출물 투여군에서 유의한 개선을 확인하였다 (p < 0.01), (도 5 D, E). Figure 5 shows the results of gene expression levels encoding antioxidant enzymes according to Experimental Example 7. Similar to the previous results, the expression level of genes Sod1 and Gpx1 encoding SOD and GPx in the menopausal induction model was significantly decreased compared to the control group, and significant improvement was confirmed in the group administered with chazugi extract ( p < 0.01), (Figure 5 D, E).

상기 실험예 1 내지 실험예 7은 부설판에 의해 고환장애가 유도된 갱년기모델에 차즈기 추출물이 미치는 효과를 확인하였다. 대조군에 비해 갱년기 유도 모델에서 고환무게 감소, 상대적 무게(체대비 무게) 감소, 정자의 수와 운동성 감소, 테스토스테론 수치 감소, 조직학적 변화가 관찰되었으나 차즈기 추출물 투여 시, 악화된 갱년기 증상들이 유의하게 개선되었으며 고환조직 내 항산화 효소 활성 증가 및 MDA 농도를 유의하게 감소시켰다.Experimental Examples 1 to 7 above confirmed the effect of Chazugi extract on a menopausal model in which testicular disorders were induced by busulfan. Compared to the control group, a decrease in testicular weight, a decrease in relative weight (weight-to-body weight), a decrease in the number and motility of sperm, a decrease in testosterone level, and histological changes were observed in the menopausal induction model. However, when chazugi extract was administered, the menopausal symptoms significantly worsened. It was improved, and antioxidant enzyme activity increased and MDA concentration in testicular tissue was significantly reduced.

이와 같은 결과를 종합했을 때, 차즈기추출물은 노화로 인한 테스토스테론 수치 감소와 함께 증가하는 갱년기 증상들을 완화하고 항산화효소를 활성화하여 남성건강 개선에 도움을 줄 것으로 사료된다. Considering these results, it is believed that Chazugi extract will help improve men's health by relieving menopausal symptoms that increase with decreased testosterone levels due to aging and activating antioxidant enzymes.

<차즈기 추출물을 이용한 건강식품 제조><Manufacture of health foods using chazugi extract>

차즈기 잎 추출물을 유효성분으로 하는 갱년기 남성건강 개선용 건강기능식품 조성물은 정제 및 캡슐제, 연질 캡슐제, 과립제, 액제 형태로 제조될 수 있다. A health functional food composition for improving menopausal men's health containing chazugi leaf extract as an active ingredient can be manufactured in the form of tablets, capsules, soft capsules, granules, and liquid.

본원발명의 또 다른 실시 형태에 따르면, 상기 조성물은 음료 첨가제로 제조할 수 있다. 상기 갱년기 남성건강 개선용 건강기능식품은 상기 차즈기 잎추출물을 유효성분으로 포함하는 조성물이 0.01 내지 99.9중량%로 포함되도록 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸, 경피제, 좌제 또는 멸균 주사용 액으로 제형화하여 제조할 수 있다.According to another embodiment of the present invention, the composition can be prepared as a beverage additive. The health functional food for improving menopausal men's health is powder, granule, tablet, capsule, suspension, emulsion, syrup, aerosol, transdermal agent to contain 0.01 to 99.9% by weight of the composition containing the Chazugi leaf extract as an active ingredient. , can be manufactured by formulating a suppository or sterile injectable solution.

갱년기 남성 건강에 따른 관심이 증가함에 따라 부작용이 없는 자연유래의 갱년기 남성건강 개선용 조성물과 이를 포함하는 건강식품을 제공함으로써 많은 수요가 기대됨으로 관련 사업 종사자의 이익 제고에 보탬이 됨으로 산업상 이용가능성이 있다. As interest in menopausal men's health increases, a lot of demand is expected by providing naturally derived compositions for improving menopausal men's health without side effects and health foods containing them, which will help increase profits for those involved in the business and have industrial applicability. There is.

Claims (3)

차즈기 열수 추출물을 유효성분으로 포함하는 갱년기 남성건강 개선용 건강기능식품 조성물
Health functional food composition for improving menopausal health containing Chazugi thermal water extract as an active ingredient
청구항 1의 조성물은 유효성분으로 포함하는 갱년기 남성건강 개선용 건강기능식품
The composition of claim 1 is a health functional food for improving menopausal health containing the composition as an active ingredient.
제2항에 있어서, 건강기능식품은 약제학적으로 허용 가능한 담체 부형제 또는 이들의 혼합물을 더 포함하고, 조성물의 제형이 정제, 캡슐제, 연질캡슐제, 환제, 과립제 및 드링크제를 포함하는 군에서 선택된 어느 하나로 제조된 것을 특징으로 하는 갱년기 남성건강 개선용 건강기능식품The method of claim 2, wherein the health functional food further comprises a pharmaceutically acceptable carrier excipient or a mixture thereof, and the dosage form of the composition is selected from the group including tablets, capsules, soft capsules, pills, granules, and drinks. Health functional food for improving menopausal health, characterized by being manufactured from one of the following:
KR1020220073206A 2022-06-16 2022-06-16 Health functional food composition for improving menopausal men's health containing Perilla frutescens var. acuta Kudo extract KR20230172710A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020220073206A KR20230172710A (en) 2022-06-16 2022-06-16 Health functional food composition for improving menopausal men's health containing Perilla frutescens var. acuta Kudo extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020220073206A KR20230172710A (en) 2022-06-16 2022-06-16 Health functional food composition for improving menopausal men's health containing Perilla frutescens var. acuta Kudo extract

Publications (1)

Publication Number Publication Date
KR20230172710A true KR20230172710A (en) 2023-12-26

Family

ID=89320445

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020220073206A KR20230172710A (en) 2022-06-16 2022-06-16 Health functional food composition for improving menopausal men's health containing Perilla frutescens var. acuta Kudo extract

Country Status (1)

Country Link
KR (1) KR20230172710A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150038906A (en) 2013-10-01 2015-04-09 주식회사한국전통의학연구소 Pharmaceutical Composition Comprising Herbal Extracts for Preventing or Treating late Onset Hypogonadism and Functional Food Comprising This Extracts
KR20180000136A (en) 2016-06-22 2018-01-02 재단법인 전남생물산업진흥원 Health food for man climacterium improvement comprising garlic, scallion, wild chive, ginger, chive and pharmaceutical composition for preventing and treating man climacterium
KR101870940B1 (en) 2016-04-15 2018-06-27 한국인스팜(주) health food composition for improving andropause syndrome
KR20200072148A (en) 2018-12-12 2020-06-22 세명대학교 산학협력단 Compositions for Improving Andropause Using Hybrid Oriental Medicine Materials and Health food using this same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150038906A (en) 2013-10-01 2015-04-09 주식회사한국전통의학연구소 Pharmaceutical Composition Comprising Herbal Extracts for Preventing or Treating late Onset Hypogonadism and Functional Food Comprising This Extracts
KR101870940B1 (en) 2016-04-15 2018-06-27 한국인스팜(주) health food composition for improving andropause syndrome
KR20180000136A (en) 2016-06-22 2018-01-02 재단법인 전남생물산업진흥원 Health food for man climacterium improvement comprising garlic, scallion, wild chive, ginger, chive and pharmaceutical composition for preventing and treating man climacterium
KR20200072148A (en) 2018-12-12 2020-06-22 세명대학교 산학협력단 Compositions for Improving Andropause Using Hybrid Oriental Medicine Materials and Health food using this same

Similar Documents

Publication Publication Date Title
Telefo et al. Ethnopharmacological survey of plants used for the treatment of female infertility in Baham, Cameroon
Ghazanfar Arabian medicinal plants
Das et al. A few traditional medicinal plants used as antifertility agents by ethnic people of Tripura, India
Ogunsola et al. Moringa plant parts consumption had effects on reproductive functions in male and female rat models
Manda et al. Phytopharmacological Review on Date Palm (Phoenix dactylifera).
KR100686950B1 (en) A composition for improving generative of male
ES2948114T3 (en) Composition comprising pollen and/or pistil extracts, associated preparation and use procedure
Ebeye et al. The histological effect of Cnidoscolus aconitifolius aqueous leaf extracts on the archetecture of the ovary, testis and sperm cells of adult wistar rats
María et al. Neurobehavioral and toxicological effects of an aqueous extract of Turnera diffusa Willd (Turneraceae) in mice
Singh et al. Ethnomedicinal plants used in sexual disorder in Balangir and Deogarh districts, Odisha, India
KR100688252B1 (en) Composition for improving male sexual function
Perumal et al. Herbal treatment in animal reproduction
JP2003507046A (en) Natural tea for correcting male impotence and method for producing the same
Jain et al. Antiimplantation and antiestrogenic activity of Boerhaavia Diffusa root extract in female albino rats
KR20230172710A (en) Health functional food composition for improving menopausal men&#39;s health containing Perilla frutescens var. acuta Kudo extract
Aderolu et al. Dietary effects of Cissus populnea and Securidaca longepedunculata aqeous leave extracts on reproductive, haematological and biochemical parameters of Clarias gariepinus (Burchell, 1822) brood stocks
KR20210146483A (en) Gongjindan composition containing rust extracts as deer antlers extract and red ginseng extract
Osawaru et al. Plants Used in the Management and Treatment of Female Reproductive Health Issues: Case Study from Southern Nigeria
Zabbey et al. Evaluation of the Hydroethanolic Fruit Extract of Solanum aethiopicum (Garden Egg) on the Concentration of Reproductive Hormones, Sperm Parameters and Histology of the Testis of Male Wistar Rats
Emmanuel et al. Effect of methanol seed extract of Mucuna urens (l) medic on sexual behaviour and sperm parameters in male albino wistar rats
Anandanayaki et al. Pharmacognostical and phytochemical studies on Andrographis Echioides (L.) Nees
Kumbhare Clinical Evaluation of Vrushya Activity of Amalaki Swaras Abhavit Amalaki Choorna
Mahmoud et al. Comparative study on the effect of Eurycoma longifolia and Smilax myosotiflora on male rats fertility
Bhandare et al. NUTRITION ASSISTANCE IN MUCORMYCOSIS, A VALUE-ADDED PRODUCT OF: TINOSPORA CORDIFOLIA.
Pyngrope et al. Phytopharmacological Review of Vitex Agnus-Castus (Verbenaceae) For The Treatment of Various Female Reproductive Disorders